Loading patent…
AssigneeGemVax AS
InventorsGustay Gaudernack, Jon Amund Eriksen, Mona Møller, Marianne Klemp Gjertsen, Ingvil Sæterdal, Stein Sæbøe-Larsen
Estimating the term…
This invention relates to proteins or peptides that elicit T cell mediated immunity, and to cancer vaccines and compositions for anti-cancer treatment comprising such proteins or peptide fragments. This invention also relates to pharmaceutical compositions comprising the proteins or peptides and methods for generating T lymphocytes capable of recognizing and destroying tumor cells in a mammal. More specifically, a telomerase protein or peptide for use in a method of treatment or prophylaxis of cancer is provided. In a preferred embodiment, the method comprises generating a T cell response against telomerase.
An isolated peptide capable of generating a T cell response directed against telomerase, said peptide consisting of 16 to 25 amino acids and consisting essentially of the amino acid sequence SEQ ID NO:2.
An isolated peptide consisting of the amino acid sequence SEQ ID NO:2.
Dependencies are inferred from the claim text.